Why it fits
Dry mouth, constipation, urinary retention, blurry vision, confusion, delirium, tachycardia, hot dry skin
Loading…
Dry mouth, constipation, urinary retention, blurry vision, confusion, delirium, tachycardia, hot dry skin
Severe delirium, ileus, urinary retention, hyperthermia, arrhythmia.
Temporal association with antipsychotic initiation, dose change, or depot timing.
Separates the Medication Side Effects / Iatrogenic Toxicity / QT Risk group. It is not specific to Anticholinergic burden.
Applies to the Medication Side Effects / Iatrogenic Toxicity / QT Risk group — not specific to Anticholinergic burden
Rows marked “Whole group”: Applies to the Medication Side Effects / Iatrogenic Toxicity / QT Risk group — not specific to Anticholinergic burden
Dry mouth, constipation, urinary retention, blurry vision, confusion, delirium, tachycardia, hot dry skin
Severe delirium, ileus, urinary retention, hyperthermia, arrhythmia.
Applies to the Medication Side Effects / Iatrogenic Toxicity / QT Risk group.
Temporal association with antipsychotic initiation, dose change, or depot timing.
Applies to the Medication Side Effects / Iatrogenic Toxicity / QT Risk group.
Constipation with clozapine is a red flag, not a nuisance side effect Clozapine constipation and myocarditis are high-risk problems Escalate early, review bowels deliberately, maintain active surveillance during early titration Early activation is a common misread Clinical toxicity can occur even when history suggests a "usual dose" Check ammonia if unexplained confusion develops on valproate
Applies to the Medication Side Effects / Iatrogenic Toxicity / QT Risk group.
ECG / QT assessment, Urea, electrolytes, creatinine, Inflammatory markers (CRP/ESR), Creatine kinase
Applies to the Medication Side Effects / Iatrogenic Toxicity / QT Risk group.
None listed
Clinical reference — not validated decision support. Review before use.